Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

Launched by ANDREA GOLDMANN · Apr 29, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the outcomes of thyroid surgery, known as thyroidectomy, for patients with Graves' disease or thyroid problems caused by a medication called amiodarone. The main goal is to find out if the risk of complications during and after the surgery is different depending on the hormone levels of patients before the procedure. This information will help doctors understand how to better manage care for these patients.

To participate in the trial, you need to be an adult (18 years or older) who is scheduled for surgery to treat Graves' disease or amiodarone-induced thyroid problems, and your condition must be confirmed by medical tests. If you join, your surgery details will be collected and added to a registry to help with future research, but your treatment will remain the same as planned. It's important to note that this study is not yet recruiting participants, and certain individuals, such as children, pregnant women, or those who can't give consent, will not be eligible to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥ 18 years of age) undergoing surgical treatment for Graves' disease or Amiodarone-induced thyrotoxicosis (AIT) with biochemically confirmed hyperthyroidism or on specific medication for the treatment of Graves' disease or AIT.
• • Patients providing signed informed consent.
• Exclusion Criteria:
• • Children and minors (\<18 years).
• • Pregnant women.
• • Patients unable or unwilling to provide informed consent due to language barriers or intellectual limitations.
• • Patients undergoing concurrent parathyroidectomy for primary or secondary hyperparathyroidism, lymph node clearance, or redo surgery.
• • Surgical procedures performed for other reasons than Graves' disease or AIT